Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

Overview of attention for article published in BMC Cancer, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 19 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,697 followers.

RT @ozlemsln: Our new article on “Preclinical Evaluation and RPPA-based profiling of PI3K and MEK inhibitors in Endometrial cancer” is now…

09 Feb 2018

Reply Repost Favourite

RT @ozlemsln: Our new article on “Preclinical Evaluation and RPPA-based profiling of PI3K and MEK inhibitors in Endometrial cancer” is now…

09 Feb 2018

Reply Repost Favourite

Our new article on “Preclinical Evaluation and RPPA-based profiling of PI3K and MEK inhibitors in Endometrial cancer” is now out :) : https://t.co/HkEUISVUg5

09 Feb 2018

Reply Repost Favourite